| Literature DB >> 26784526 |
Marta Bosch1, Alba Fajardo2, Rafael Alcalá-Vida3, Andrea Fernández-Vidal2, Francesc Tebar4, Carlos Enrich4, Francesc Cardellach5, Esther Pérez-Navarro3, Albert Pol6.
Abstract
Niemann-Pick C disease is a neurovisceral disorder caused by mutations in the NPC gene that result in systemic accumulation of intracellular cholesterol. Although neurodegeneration defines the disease's severity, in most patients it is preceded by hepatic complications such as cholestatic jaundice or hepatomegaly. To analyze the contribution of the hepatic disease in Niemann-Pick C disease progression and to evaluate the degree of primary and secondary hepatic damage, we generated a transgenic mouse with liver-selective expression of NPC1 from embryonic stages. Hepatic NPC1 re-expression did not ameliorate the onset and progression of neurodegeneration of the NPC1-null animal. However, the mice showed reduced hepatomegalia and dramatic, although not complete, reduction of hepatic cholesterol and serum bile salts, bilirubin, and transaminase levels. Therefore, hepatic primary and secondary cholesterol deposition and damage occur simultaneously during Niemann-Pick C disease progression.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26784526 DOI: 10.1016/j.ajpath.2015.12.002
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307